Ethnomedicinal Plants with Protective Effects against Beta-Amyloid Peptide (Aβ)1-42 Indicate Therapeutic Potential in a New In Vivo Model of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with unmet medical need. This investigation consisted of testing a range of ethanolic ethnomedicinal plant extracts (n = 18) traditionally used in the treatment of disorders such as anxiety, delirium, and memory loss. They were then screened for in vitro inhibitory activity against acetylcholinesterase (AChE), butylcholinesterase (BuChE), beta-secretase 1/beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1), and antioxidant activities. Plants with potent activities were further characterised using a recently developed in vivo model of AD, Globodera pallida. The ability of phytoextracts to protect this organism against amyloid-beta Aβ (1-42) exposure was assessed by measuring chemosensing, survival rate, production of reactive oxygen species (ROS), and antioxidant responses. Extracts (n = 5) from Juglans regia (leaves), Ellettaria cardamomum (seeds), Cinnamomum zeylanicum (bark), Salvia officinalis (leaves/flowers), and Hypericum perforatum (flowers) exerted concentration-dependent inhibitory activities against AChE and BuChE. Three of these plant extracts (i.e., J. regia, E. cardamomum, and S. officinalis) possessed strong concentration-dependent inhibitory activity against BACE1. Furthermore, the five selected medicinal plant extracts not only enhanced significantly (p < 0.05) the nematode’s chemosensing, survival rate, and antioxidant responses (i.e., anti-ROS production, mitochondrial reductase activity, oxidized glutathione (GSSG) to reduced glutathione (GSH) ratio), but also greatly restored (p < 0.05) in a concentration-dependent manner the Aβ (1-42)-induced deleterious changes in these same parameters. In brief, this investigation highlights plant extracts with strong anti-AD activities which could be trialled as novel therapeutic supplements or undergo further biodiscovery research.

[1]  F. Menaa,et al.  Globodera pallida, a non-transgenic invertebrate as a new model for investigating Alzheimer’s disease (and other proteinopathies)? , 2022, Neural regeneration research.

[2]  F. Menaa,et al.  Assessment and Validation of Globodera pallida as a Novel In Vivo Model for Studying Alzheimer’s Disease , 2021, Cells.

[3]  V. B. Souza,et al.  Evaluation of the release profile, stability and antioxidant activity of a proanthocyanidin-rich cinnamon (Cinnamomum zeylanicum) extract co-encapsulated with α-tocopherol by spray chilling. , 2017, Food research international.

[4]  Wenmin Liu,et al.  Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. , 2017, European journal of medicinal chemistry.

[5]  S. Khalifeh,et al.  The effect of Elettaria cardamomum extract on anxiety-like behavior in a rat model of post-traumatic stress disorder. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  R. Bhattacharya,et al.  Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions. , 2017, Biotechnology advances.

[7]  R. Martins,et al.  Possible Role of Common Spices as a Preventive and Therapeutic Agent for Alzheimer's Disease , 2017, International journal of preventive medicine.

[8]  H. Lou,et al.  Cinnamaldehyde Analogues as Potential Therapeutic Agents. , 2016, Mini reviews in medicinal chemistry.

[9]  B. Shukitt-Hale,et al.  Serum metabolites from walnut-fed aged rats attenuate stress-induced neurotoxicity in BV-2 microglial cells , 2016, Nutritional neuroscience.

[10]  Ying Sun,et al.  Development and Structural Modification of BACE1 Inhibitors , 2016, Molecules.

[11]  Adrian L. Lopresti.  Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects , 2016, Drugs in R&D.

[12]  K. Shimizu,et al.  Acetylcholine esterase inhibitors and melanin synthesis inhibitors from Salvia officinalis. , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[13]  M. Wink,et al.  Carlina acaulis Exhibits Antioxidant Activity and Counteracts Aβ Toxicity in Caenorhabditis elegans , 2016, Molecules.

[14]  A. Camins,et al.  Current Research Therapeutic Strategies for Alzheimer's Disease Treatment , 2016, Neural plasticity.

[15]  Wei-Dong Chen,et al.  β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease , 2015, Front. Pharmacol..

[16]  D. Vattem,et al.  Potential neuroprotective effects of cinnamon , 2015 .

[17]  J. Hafsa,et al.  Effects of sage extract on memory performance in mice and acetylcholinesterase activity. , 2015, Annales pharmaceutiques francaises.

[18]  T. Manivasagam,et al.  Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson’s Disease , 2015, Neurochemical Research.

[19]  M. Ali-Shtayeh,et al.  In-vitro screening of acetylcholinesterase inhibitory activity of extracts from Palestinian indigenous flora in relation to the treatment of Alzheimer’s disease , 2014 .

[20]  Xinglong Wang,et al.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[21]  Chunbo Li,et al.  Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP‑2 and NF‑κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease. , 2014, Molecular medicine reports.

[22]  P. Reubroycharoen,et al.  Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. , 2014, European journal of medicinal chemistry.

[23]  Y. Teng,et al.  Compound danshen tablet ameliorated aβ25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophins , 2014, BMC Complementary and Alternative Medicine.

[24]  J. Vladić,et al.  Acetylcholinesterase Inhibitory, Antioxidant and Phytochemical Properties of Selected Medicinal Plants of the Lamiaceae Family , 2014, Molecules.

[25]  M. Joghataei,et al.  The Protective Role of Carnosic Acid against Beta-Amyloid Toxicity in Rats , 2013, TheScientificWorldJournal.

[26]  F. Khodagholi,et al.  Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect , 2013, Current neuropharmacology.

[27]  I. Orhan,et al.  Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L. (St. John's wort) , 2013 .

[28]  A. Feizi,et al.  Effect of Ginger and Cinnamon Intake on Oxidative Stress and Exercise Performance and Body Composition in Iranian Female Athletes , 2013, International journal of preventive medicine.

[29]  Dong Hyun Kim,et al.  Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease. , 2013, European journal of pharmacology.

[30]  A. Cesario,et al.  From traditional European medicine to discovery of new drug candidates for the treatment of dementia and Alzheimer's disease: acetylcholinesterase inhibitors. , 2013, Current medicinal chemistry.

[31]  Hong-Qi Yang,et al.  Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease , 2013, Translational Neurodegeneration.

[32]  M. Shabani,et al.  Walnut consumption protects rats against cisplatin-induced neurotoxicity. , 2012, Neurotoxicology.

[33]  C. Parsons,et al.  Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections , 2012, British journal of pharmacology.

[34]  M. Rout,et al.  Modulation of in vitro activity of zymogenic and mature recombinant human β‐secretase by dietary plants , 2012, The FEBS journal.

[35]  S. Kumar,et al.  Screening Of Traditional Indian Spices For Inhibitory Activity Of Acetylcholinesterase And Butyrylcholinesterase Enzymes , 2012 .

[36]  N. A. Taha,et al.  Utility and importance of walnut, Juglans regia Linn: A review , 2011 .

[37]  I. Orhan,et al.  In vitro neuroprotective effects of the leaf and fruit extracts of Juglans regia L. (walnut) through enzymes linked to Alzheimer's disease and antioxidant activity , 2011, International journal of food sciences and nutrition.

[38]  N. Inestrosa,et al.  Interactions of AChE with Aβ Aggregates in Alzheimer’s Brain: Therapeutic Relevance of IDN 5706 , 2011, Front. Mol. Neurosci..

[39]  M. Essa,et al.  Protective Effects of Walnut Extract Against Amyloid Beta Peptide-Induced Cell Death and Oxidative Stress in PC12 Cells , 2011, Neurochemical Research.

[40]  E. Gazit,et al.  Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models , 2011, PloS one.

[41]  M. Serralheiro,et al.  Acetylcholinesterase inhibition and antioxidant activity of the water extracts of several Hypericum species. , 2010 .

[42]  D. Casey,et al.  Drugs for Alzheimer's disease: are they effective? , 2010, P & T : a peer-reviewed journal for formulary management.

[43]  Ian Parker,et al.  Calcium Signaling and Amyloid Toxicity in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[44]  A. Kiss,et al.  Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity , 2010, Acta pharmaceutica.

[45]  Laura Dosanjh,et al.  Cinnamomum cassia Bark in Two Herbal Formulas Increases Life Span in Caenorhabditis elegans via Insulin Signaling and Stress Response Pathways , 2010, PloS one.

[46]  K. Amin,et al.  Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon. , 2009, International journal of clinical and experimental medicine.

[47]  S. Moselhy,et al.  Hepatoprotective effect of cinnamon extracts against carbon tetrachloride induced oxidative stress and liver injury in rats. , 2009, Biological research.

[48]  D. Pradhan,et al.  Antidepressant Activity of Juglans regia L . Fruit Extract , 2009 .

[49]  A. Kriško,et al.  Antioxidant and acetylcholinesterase inhibiting activity of several aqueous tea infusions in vitro. , 2008 .

[50]  B. Shukitt-Hale,et al.  Dose-dependent effects of walnuts on motor and cognitive function in aged rats , 2008, British Journal of Nutrition.

[51]  A. Lleó.  Current Therapeutic Options for Alzheimer’s Disease , 2007, Current genomics.

[52]  D. Bhatnagar,et al.  Free radical scavenging activity, metal chelation and antioxidant power of some of the Indian spices , 2007, BioFactors.

[53]  D. Kennedy,et al.  The psychopharmacology of European herbs with cognition-enhancing properties. , 2006, Current pharmaceutical design.

[54]  H. Hosseinzadeh,et al.  The pharmacological effects of Salvia species on the central nervous system , 2006, Phytotherapy research : PTR.

[55]  Angelo A. Izzo,et al.  The Spice Sage and Its Active Ingredient Rosmarinic Acid Protect PC12 Cells from Amyloid-β Peptide-Induced Neurotoxicity , 2006, Journal of Pharmacology and Experimental Therapeutics.

[56]  Mark S Butler,et al.  The role of natural product chemistry in drug discovery. , 2004, Journal of natural products.

[57]  Jerzy Wegiel,et al.  Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. , 2004, Current Alzheimer research.

[58]  E. Okello,et al.  Butyryl‐ and acetyl‐cholinesterase inhibitory activities in essential oils of Salvia species and their constituents , 2004, Phytotherapy research : PTR.

[59]  Kenjiro Ono,et al.  Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.

[60]  C. S. Patil,et al.  Protective Effect of Flavonoids against Aging- and Lipopolysaccharide-Induced Cognitive Impairment in Mice , 2003, Pharmacology.

[61]  E. Perry,et al.  Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers , 2003, Pharmacology Biochemistry and Behavior.

[62]  Mohammad Reza Mohammadi,et al.  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.

[63]  N. Perry,et al.  Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders , 2003, Phytotherapy research : PTR.

[64]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.